Norwegian Study on District Treatment of ST-Elevation Myocardial Infarction

Acute Myocardial Infarction Clinical Trial

Official title:

Benefits and Costs in Two Different Strategies for Treating Acute Myocardial Infarction With ST-Elevation.

Clinical Trial Details — Status: Unknown status

Administrative data

• NCT number: NCT00161005
• Other study ID #: 2935-0304 (UUS)
• Secondary ID: 2004-162 (Helse
• Status: Unknown status
• Phase: N/A
• First received: September 9, 2005
• Last updated: April 16, 2009
• Start date: February 2005
• Est. completion date: December 2009

Study information

• Verified date: April 2009
• Source: Ullevaal University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In the district areas of Norway patients with acute myocardial infarction with ST-elevation, are treated with thrombolysis. An increasing part of them receives thrombolysis before arrival to the local hospital.Usually these patients have been sent to an invasive center if thrombolysis fails or the patient gets ischemic symptoms during the stay.

This study will compare this strategy against immediate transportation to an invasive center after the patient has received thrombolysis.

Recruitment information / eligibility

• Status: Unknown status
• Enrollment: 266
• Est. completion date: December 2009
• Est. primary completion date: June 2009
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Duration of painless than 6 hours.

• ST-segment elevation of at least 0.1 mV in two or more extremity leads or at least 0.2 mV in two or more precordial leads.

• The patient is getting thrombolysis.

• Time to reach an invasive center is more than 1 hour.

• Age 18-75 years.

Exclusion Criteria:

• Known serious renal failure (creatinin > 250 mmol/l)

• Pregnancy

• Cardiogenic chock

• Life threatening arrythmias

• Other serious diseases with life expectancy less than 1 year.

• Inability to perform an informed consent

Related Conditions & MeSH terms

• Acute Myocardial Infarction
• Infarction
• Myocardial Infarction
• ST Elevation Myocardial Infarction

Intervention

Procedure:
• PCI
Immediate transport to invasive center after thrombolysis

Locations

Country	Name	City	State
Norway	Ulleval University Hospital	Oslo

Sponsors (2)

Lead Sponsor	Collaborator
Ullevaal University Hospital	Helse Innlandet

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Death , myocardial infarction ,stroke or ischemia during 12 months.		12 months
Primary	Costs during 12 months.		12 months
Secondary	Size of infarction.		3 months
Secondary	Complications		1 month